A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (25 and 50 mg/Day) of DVS SR Tablets in Adult Outpatients With Major Depressive Disorder
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (25 and 50 mg/Day) of DVS SR Tablets in Adult Outpatients With Major Depressive Disorder
The primary purpose of this study is to compare the antidepressant efficacy and safety of two doses of DVS SR (25 and 50 mg/day) in the treatment of adults with Major Depressive Disorder. The study will also assess changes in sexual function and general and functional quality of life outcomes.
Inclusion Criteria:
Exclusion Criteria:
Kumagaya, Gunma 3600032, Japan
Kanzaka, Saga-ken 8420192, Japan
Bunkyo, Tokyo 1120012, Japan
Setagaya-ku, Tokyo 1540004, Japan
Shinagawa, Tokyo 1410021, Japan
Shinagawa, Tokyo 1410022, Japan
Shinagawa, Tokyo 1420021, Japan
Shinjyuku, Tokyo 1600023, Japan
Suginami, Tokyo 1660003, Japan